Summary & Overview
CPT 89257: Identification of Sperm from Aspirated Specimens
CPT 89257 captures laboratory identification of sperm from aspirated sources other than seminal fluid or semen, a targeted reproductive medicine procedure with importance for infertility evaluation and assisted reproduction workflows. Nationally, accurate coding for this specialized laboratory service supports clinical documentation, care planning for male-factor infertility, and appropriate claims adjudication across payers. Key commercial payers relevant to coverage and billing considerations include Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare.
Readers will gain a concise understanding of the clinical context for 89257, how it relates to other semen and sperm analysis codes, and implications for laboratory-based reproductive services. The summary covers coding scope and clinical use, common clinical indications for testing (such as male infertility diagnoses), and the placement of this code within reproductive medicine service lines. It also identifies common modifiers and related procedure codes that frequently appear alongside 89257 in billing and claims workflows. Where specific service-line metadata is missing, the publication notes that information is not available in the input. This overview is intended to orient billing staff, clinical coders, and policy analysts to the purpose and typical application of 89257 in laboratory reproductive medicine.
CPT Code Overview
CPT 89257 describes the laboratory identification of sperm obtained by aspiration from sources other than seminal fluid or semen. This procedure falls under Reproductive Medicine Procedures and involves microscopic and laboratory techniques to detect and identify sperm cells in aspirated specimens.
Typical site of service: Laboratory (POS 81)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 34-year-old male with a history of infertility is referred by his reproductive endocrinologist for laboratory testing after a prior semen analysis demonstrated absent or very low sperm. The patient undergoes a testicular or epididymal aspiration performed in the outpatient clinic or operating room by the urologist or reproductive specialist. The aspirated specimen is sent to the laboratory (POS 81) where a clinical laboratory analyst performs identification of sperm from the aspiration specimen, separate from seminal fluid or semen. The laboratory documents presence or absence of sperm and reports findings to the ordering reproductive endocrinologist or urologist for consideration in assisted reproductive techniques such as intracytoplasmic sperm injection (ICSI).
Coding Specifications
Modifier 26 is used to report the professional component when a physician or laboratory director performs or interprets the test and bills for the professional work.
Modifier TC is used to report the technical component when the facility or laboratory bills for the technical work, including specimen processing, technician time, and equipment.
Provider Taxonomies and Specialties
-
207V00000X: Obstetrics & Gynecology Physician — physicians providing female reproductive and obstetric care; may order or coordinate reproductive testing. -
207U00000X: Clinical Pathology/Laboratory Medicine Physician — physicians who oversee laboratory testing, interpretation, and quality control for clinical specimens. -
207ZP0102X: Reproductive Endocrinology Physician — specialists in reproductive medicine who manage infertility and coordinate assisted reproduction services.
Related Diagnoses
-
N46.9— Male infertility, unspecifiedRelevance: General diagnosis indicating male factor infertility; may prompt procedures to identify sperm from non-semen sources.
-
N46.01— AzoospermiaRelevance: Absence of sperm in ejaculate; aspiration of testicular or epididymal tissue with sperm identification is clinically relevant for diagnosis and treatment planning.
-
N46.11— OligospermiaRelevance: Low sperm count in ejaculate; aspiration and laboratory identification may be performed when ejaculated samples are inadequate for assisted reproduction.
-
N46.8— Other male infertilityRelevance: Catch-all category for male infertility etiologies where aspiration-based sperm identification may be indicated.
-
N46.02— CryptozoospermiaRelevance: Extremely low levels of sperm detectable only after centrifugation of semen or by aspiration; laboratory identification from aspiration sources is directly applicable.
Related CPT Codes
-
89260- Sperm isolation; simple prepRelation: Used to isolate sperm from samples for use in assisted reproduction; may follow identification of sperm in an aspiration when simple preparation suffices.
-
89261- Sperm isolation; complex prepRelation: Used when more complex laboratory separation techniques are required after sperm identification from aspiration.
-
89300- Semen analysis; presence and/or motility of spermRelation: Semen analysis assesses ejaculated semen and may be performed prior to aspiration procedures; serves as a complementary diagnostic test.
-
89320- Semen analysis; volume, count, motility, and differentialRelation: Provides comprehensive semen parameters for diagnostic evaluation; may be part of the pre-aspiration workup.
-
89321- Semen analysis; sperm presence and motility of sperm, if performedRelation: Alternative or adjunct semen testing; can be used in conjunction with or prior to sperm identification from aspiration.
National Reimbursement Benchmarks
Across national payers, the average commercial benchmark represented by BUCA ($36,323.60 mean) is materially higher than Medicare (no national mean provided in the input). Aetna’s mean ($211.48) sits far below BUCA’s average but above the means reported for Cigna ($74.63) and UnitedHealth Group ($76.53); Blue Cross Blue Shield shows an extreme mean driven by outlier values ($122,774.17).
Dispersion measured as the interquartile difference (P75 − P25) varies markedly. Blue Cross Blue Shield and BUCA show the widest spreads (BCBS: $217.00 range; BUCA: $119.40 range), indicating substantial variability across reporting NPIs, while UnitedHealth Group is the tightest with no spread reported (P75 = P50 = P25 = $62.20). Cigna and Aetna show moderate dispersion (Cigna: $49.00; Aetna: $47.33). The table and chart below present the full breakdown of mean rates and percentiles.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.